These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34780714)
1. Lymphatic Dysfunction Exacerbates Cutaneous Tumorigenesis and Psoriasis-Like Skin Inflammation through Accumulation of Inflammatory Cytokines. Boki H; Kimura T; Miyagaki T; Suga H; Blauvelt A; Okochi H; Sugaya M; Sato S J Invest Dermatol; 2022 Jun; 142(6):1692-1702.e3. PubMed ID: 34780714 [TBL] [Abstract][Full Text] [Related]
2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
3. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. Guo H; Li M; Liu H Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231 [TBL] [Abstract][Full Text] [Related]
4. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis. Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106 [TBL] [Abstract][Full Text] [Related]
6. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice. Liang L; Fei WM; Zhao ZQ; Hao YY; Zhang C; Cui Y; Guo XD Eur J Pharm Biopharm; 2021 Jul; 164():20-27. PubMed ID: 33895291 [TBL] [Abstract][Full Text] [Related]
7. TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production. Nakao M; Sugaya M; Fujita H; Miyagaki T; Morimura S; Shibata S; Asano Y; Sato S Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202847 [TBL] [Abstract][Full Text] [Related]
8. Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. Rai VK; Sinha P; Yadav KS; Shukla A; Saxena A; Bawankule DU; Tandon S; Khan F; Chanotiya CS; Yadav NP J Ethnopharmacol; 2020 Oct; 261():113127. PubMed ID: 32623016 [TBL] [Abstract][Full Text] [Related]
9. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related]
10. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice. Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197 [TBL] [Abstract][Full Text] [Related]
11. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway. Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468 [TBL] [Abstract][Full Text] [Related]
12. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state. Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206 [TBL] [Abstract][Full Text] [Related]
13. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice. Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916 [TBL] [Abstract][Full Text] [Related]
14. Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes. Moos S; Mohebiany AN; Waisman A; Kurschus FC J Invest Dermatol; 2019 May; 139(5):1110-1117. PubMed ID: 30684554 [TBL] [Abstract][Full Text] [Related]
15. Cyclin-Dependent kinase 9 (CDK9) inhibitor Atuveciclib ameliorates Imiquimod-Induced Psoriasis-Like dermatitis in mice by inhibiting various inflammation factors via STAT3 signaling pathway. Zhao F; Wang Y; Zuo H; Ru Y; Wang Y Int Immunopharmacol; 2024 Mar; 129():111652. PubMed ID: 38335657 [TBL] [Abstract][Full Text] [Related]
16. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice. Srikanth M; Rasool M Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087 [TBL] [Abstract][Full Text] [Related]
17. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. Morimura S; Oka T; Sugaya M; Sato S J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687 [TBL] [Abstract][Full Text] [Related]
18. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
19. The Role of Gut Microbiome in Psoriasis: Oral Administration of Okada K; Matsushima Y; Mizutani K; Yamanaka K Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392785 [TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3-TET3 Signaling. Ling S; Xu B; Luo Y; Fang X; Liu X; Wang A; Zhou Y; Zhang S; Zong W; Li W; Yao X J Invest Dermatol; 2022 Nov; 142(11):2968-2977.e10. PubMed ID: 35545140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]